BridgeBio Oncology Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BridgeBio Oncology Therapeutics, Inc.
CIK #0001869105
EDGAR Form CIK 2011 - 2025
10-K [0001869105]
10-Q [0001869105]
3 [0001869105]
4 [0001869105]
8-K [0001869105]
SC 13D [0001869105]
SC 13G [0001869105]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18]
Flynn James E Bridgebio Oncology Therapeutics Inc [2025-08-18]
Sculptor Capital LP Helix Acquisition Corp II [2025-07-24]
BlackRock Portfolio Management LLC Helix Acquisition Corp II [2025-04-15]
Price T Rowe Associates Inc /MD/ Helix Acquisition Corp II [2024-11-14]
BlackRock Inc Helix Acquisition Corp II [2024-11-08]
BlackRock Inc Helix Acquisition Corp II [2024-10-22]
Citadel Advisors LLC Helix Acquisition Corp II [2024-02-23]
Adage Capital Partners GP LLC Helix Acquisition Corp II [2024-02-23]
Helix Holdings II LLC Helix Acquisition Corp II [2024-02-20]
View All
Form 3/4/5 Subject 2011 - 2025
BridgeBio Oncology Therapeutics, Inc.
Beltran Pedro
Mehra Uneek
Wallace Eli M.
Ben Yong
Kumar Neil
Bauer Jake
BridgeBio Pharma LLC
BridgeBio Pharma, Inc.
McCormick Frank
View All
Terms | Privacy | Guide
tony@aum13f.com